Abstract

Stress is a complex human experience and having both rewarding and aversive motivational properties. The adverse effects of stress are well documented, yet many of underlying mechanisms remain unclear and controversial. Here we report that the anxiogenic properties of stress are encoded by the endogenous opioid peptide dynorphin acting in the basolateral amygdala. Using pharmacological and genetic approaches, we found that the anxiogenic-like effects of Corticotropin Releasing Factor (CRF) were triggered by CRF1-R activation of the dynorphin/kappa opioid receptor (KOR) system. Central CRF administration significantly reduced the percent open-arm time in the elevated plus maze (EPM). The reduction in open-arm time was blocked by pretreatment with the KOR antagonist norbinaltorphimine (norBNI), and was not evident in mice lacking the endogenous KOR ligand dynorphin. The CRF1-R agonist stressin 1 also significantly reduced open-arm time in the EPM, and this decrease was blocked by norBNI. In contrast, the selective CRF2-R agonist urocortin III did not affect open arm time, and mice lacking CRF2-R still showed an increase in anxiety-like behavior in response to CRF injection. However, CRF2-R knockout animals did not develop CRF conditioned place aversion, suggesting that CRF1-R activation may mediate anxiety and CRF2-R may encode aversion. Using a phosphoselective antibody (KORp) to identify sites of dynorphin action, we found that CRF increased KORp-immunoreactivity in the basolateral amygdala (BLA) of wildtype, but not in mice pretreated with the selective CRF1-R antagonist, antalarmin. Consistent with the concept that acute stress or CRF injection-induced anxiety was mediated by dynorphin release in the BLA, local injection of norBNI blocked the stress or CRF-induced increase in anxiety-like behavior; whereas norBNI injection in a nearby thalamic nucleus did not. The intersection of stress-induced CRF and the dynorphin/KOR system in the BLA was surprising, and these results suggest that CRF and dynorphin/KOR systems may coordinate stress-induced anxiety behaviors and aversive behaviors via different mechanisms.

Highlights

  • Stress is a complex human experience and has both rewarding as well as aversive motivational properties

  • These results indicate that the anxiogenic-like effects of corticotropin releasing factor (CRF) require activation of the dynorphin/kappa opioid receptors (KOR) system

  • The principal findings of this study are that stress and CRFinduce dynorphin/KOR activation in the basolateral amygdala to increase anxiety-like behavior through CRF1-R activation

Read more

Summary

Introduction

Stress is a complex human experience and has both rewarding as well as aversive motivational properties. Other groups have demonstrated that CRF has anxiogenic properties [10,11,12], and it has been posited that these effects of CRF initiate stress-induced relapse to drug seeking and drug withdrawal behaviors [3,4,6,13,14]. CRF acts directly on neurons in key regions of the central nervous system (e.g. bed nucleus of the stria terminalis and amygdalar complex) to coordinate the behavioral stress response through the activation of two receptor subtypes [15]. The processes by which CRF and the urocortins mediate stress-induced behaviors through their two receptor systems are still under active investigation

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call